-
Innovation Ranking
NewInnovation Ranking – PG&E Corp
PG&E Corp (PG&E) is an energy holding company that generates, transmits and distributes electricity. The company produces power using nuclear, hydro, fuel cell, solar and fossil fuel sources. PG&E also procures power and electric capacity, including agreements for renewable energy resources. The company procures, transports and stores natural gas. PG&E has electric power systems in the Western Electricity Coordinating Council, the Canadian provinces of Alberta and British Columbia, and parts of Mexico. It offers energy efficiency services and energy management...
-
Product Insights
PG Silesia Coal Mine
The PG Silesia Coal Mine is a coal mine in Poland. It is currently in operation. Empower your strategies with our PG Silesia Coal Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to...
-
Product Insights
Sir Adam Beck PGS
Sir Adam Beck PGS is a Hydro project located in Ontario, Canada. The project is owned by Ontario Power Generation Inc. The project came online in 1957. Empower your strategies with our Sir Adam Beck PGS report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gevokizumab in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gevokizumab in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gevokizumab in Metastatic Colorectal Cancer Drug Details: Gevokizumab (XOMA-052) is developing...
-
Product Insights
Huron (PG&E) Solar Park
Huron (PG&E) Solar Park is a solar PV project located in California, United States. The project is owned by Pacific Gas and Electric Co and was developed by Cupertino Electric Inc. The project came online in 2012. Empower your strategies with our Huron (PG&E) Solar Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
Huron (PG&E) Solar Park – 1
Huron (PG&E) Solar Park – 1 is a solar PV project located in California, United States. The project is owned by Pacific Gas and Electric Co and was developed by Cupertino Electric Inc. The project came online in 2013. Empower your strategies with our Huron (PG&E) Solar Park – 1 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Company Insights
Innovation and Patenting activity of PG&E Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of PG&E Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dordaviprone Hydrochloride in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dordaviprone Hydrochloride in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dordaviprone Hydrochloride in Acute Lymphocytic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dordaviprone Hydrochloride in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dordaviprone Hydrochloride in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dordaviprone Hydrochloride in Refractory Acute Myeloid Leukemia Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dordaviprone Hydrochloride in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dordaviprone Hydrochloride in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dordaviprone Hydrochloride in Relapsed Acute Myeloid Leukemia Drug...